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Summary. This study compares basal and induced
expression of cytochrome P4501A-CYP1A in the brain
of gilthead seabream, Sparus aurata. Larval or adult
seabream were exposed to benzo(a)pyrene -B(a)P- and
the CYP1A response was assessed by analyzing CYP1A
mRNA (RT-PCR), CYP1A protein (expression levels:
ELISA, western blotting; cellular localization:
immunohistochemistry), and CYP1A catalytic activity
(7-ethoxyresorufin-O-deethylase-EROD).
In the brain of adult S. aurata, CYP1A
immunostaining was generally detected in the
vasculature. It was present in the neuronal fibers and
glial cells of the olfactory bulbs and the ventral
telencephalon. ELISA and RT-PCR analyses confirmed
CYP1A expression in the brains of non-exposed
seabream. B(a)P exposure led to increased CYP1A
staining mainly in neuronal fibers and glial cells of the
olfactory bulbs, but also in the vascular endothelia.
EROD activity, however, could not be detected in the
brain of adult seabream, neither in control nor in
exposed fish. 
In the developing brain of S. aurata larvae,
immunohistochemical staining detected CYP1A protein
exclusively in endothelia of the olfactory placode and in
retina. Staining intensity of CYP1A slightly increases
with larval development, especially in vascular brain
endothelia. Exposing the larvae to 0.3 or 0.5 µg B(a)P/L
from hatching until 15 days post hatching (dph) did not
result in enhanced CYP1A immunostaining in the brain.
In samples of whole seabream larvae, both from controls
and BaP treatments, neither CYP1A mRNA, protein nor
catalytic activity were detectable. 
The results demonstrate that CYP1A is expressed
already and inducible in the larval brain, but that the
regional and cellular expression differs partly between
larval and adult brain. This may have implications for
the toxicity of CYP1A-inducing xenobiotics on early
and mature life stages of seabream.
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Introduction
Cytochrome P-450 monooxygenases are a multigene
family of constitutive and inducible haeme- proteins
containing enzymes, which are involved in the oxidative
metabolism of a broad range of substrates, with
physiological functions in inter-and intracellular
signalling, such as fatty acids, prostaglandins, steroids,
neurohormones, and for metabolizing lipophilic
xenobiotics and drugs (Nebert and González, 1987;
Nebert et al., 1991, 1996; Parkinson, 1995; Mansuy,
1998; Sarasquete and Segner, 2000; Hoffman and Oris,
2006). CYP enzymes may have homeostatic functions
since have been shown, in the mammalian brain, to
participate in the synthesis of neuroactive steroids and
also in cerebral blood vessel tone. Moreover, CYP
isoforms have been localized in discrete cerebral areas
and may alter the local action or concentration of
neuroactive drugs (Majewska et al., 1986; Walther et al.,
1986, 1987). 
The most intensively studied P450 gene in fish is
CYP1A (Nelson et al., 1996), which are inducible by a
wide variety of lipophilic contaminants, particularly
polychloro dibenzo dioxins (PCDDs), polycyclic
aromatic hydrocarbons (PAHs), polyhalogenated
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aromatic hydrocarbons (PHAHs) and polychloro-
biphenyls (PCBs) (Stegeman and Hahn, 1994;
Parkinson, 1995). These xenobiotics activate CYP1A
gene expression via ligand binding to the
arylhydrocarbon receptor (AhR) pathway (Nebert and
Gonzalez, 1987). As a consequence of receptor
activation, levels of CYP1A mRNA and newly
synthesized CYP1A proteins are increased and proteins
subsequently undergone processing, heme-insertion and
folding to yield the catalytically active enzymes. Each of
these steps, i.e mRNA, protein and catalytic activity, can
be analyzed with a suitable probe to detect CYP1A
induction (Goksoyr and Förlin, 1992; Sarasquete and
Segner, 2000).
Fish can be exposed to lipophilic xenobiotics via
water, sediment and/or food. Once taken up by the fish,
the contaminants may be metabolized and excreted
and/or they may produce physiological dysfunctions and
pathological alterations. The brain may be particularly
vulnerable to damage by toxic compounds due to the
limited regenerative capability of the neurons. The
blood-brain barrier which renders some protection to the
brain by preventing the entry of many types of
circulating toxic molecules is well developed in
mammals but might be not fully developed in fish
species (Andreas, 1994). Lipophilic compounds such as
the AhR-activating HAHs and PAHs may diffuse
through the endothelial cells of the brain vessels, and in
fact, high accumulation factors of these compounds in
fish brain have been reported (Varanasi et al., 1989).
CYP1A-mediated in situ metabolism and cellular
toxicity of xenobiotics in the brain may have far-
reaching consequences, causing disruption of neuronal
and neuroendocrine functions (Andersson et al., 1993;
Andersson and Goksoyr, 1994; Huang et al., 2000).
Adverse consequences of xenobiotic accumulation and
activation of the AhR pathway may differ between larval
and adult fishes, as the larval brain is still under
differentiation, however, to date it is not known whether
at all larval brain expresses an inducible AhR 
pathway. 
The present study aims to compare CYP1A
expression and potential benzo(a)pyrene –B(a)P-
induction in the brains of developing as well as adult
seabream, Sparus aurata. For this purpose, a battery of
molecular, cellular and biochemical approaches was
used to localize CYP1A cellular and regional
distribution in the brain, as well as to quantify CYP1A
mRNA (by means of RT-PCR) and protein levels
(Western Blot, ELISA), as well as CYP1A catalytic
activities (7-ethoxyresorufin-O-deethylase –EROD-
activity) in the brain. For the larvae, both the
endotrophic and exotrophic nutrition phases were
investigated. The gilthead seabream, Sparus aurata, is a
protandric species which develops as male during the
first year of life and later undergoes sex conversion into
females. The use of all-male fish has the advantage to
exclude a possible sex influence on the CYP1A
response. Sparus aurata was selected as an experimental
species because of its economical importance, and
because the morphological and neuroanatomical
description of its central nervous system, CYP1A
immunodistribution and cerebral larvae developing was
already studied and described in detail for Sparus aurata
and Solea senegalensis (Muñoz-Cueto et al., 2001;
Sarasquete et al., 1999, 2001; Ortiz-Delgado et al., 2002;
Piñuela et al., 2004). This anatomical knowledge
provides an indispensable tool for the interpretation of





Immature male specimens of gilthead seabream,
Sparus aurata (1 year old, average weight: 250-300 gr)
were obtained from CUPIMAR S.A (San Fernando,
Cádiz, Spain). Until the xenobiotics exposure, specimens
were kept in tanks during 2 weeks for acclimatisation.
The tanks were supplied with continuously flowing
seawater at constant temperature (19±1°C). 
After the acclimatisation, fish were randomly
distributed to the experimental tanks for 20 days and
submitted to the following treatments: (a) only vehicle
added, toluene, as control, and (b) exposure to 100 µg/L
B(a)P (SIGMA, Aldrich). Treatments were applied in
triplicate, with 12 fish per each 120-L experimental tank.
A stock solution of B(a)P was prepared in toluene and
added to the water in suitable quantities to give nominal
concentrations of B(a)P. The maximum solvent
concentration in the water was 0.05 µl/L toluene. 
The fish were exposed to the toxicant under semi-
static conditions. The water was renewed every 24
hours, followed by the addition of suitable quantities of
B(a)P. Before the experiments were initiated, tanks were
filled with water and B(a)P solutions were added and
maintained during 24 h in order to guarantee complete
adsorption of the compounds on the walls. Fish samples
were taken after 5, 10 15 and 20 days of the
experimental period (3 fish per each sampling point and
treatment group). At sampling, fish were then
anaesthetised by immersion in 2-phenoxyethanol (3
ml/L) and disected for immnuohistochemical and
biochemical purposes. Water temperature (18.8±0.2°C),
pH (7.5±0.2), NO2- (<0.1 mg.L-1), NO3- (<8mg.L-1),
NH4+ (<3 mg.L-1), dissolved oxygen (8.3±0.3 mg.L-1)
and salinity (32‰) were measured daily during the
experimental period. No mortalities were recorded
during experimental exposure treatment. 
Samples of brain from control and exposed fish were
taken at the end of the experimental period. Tissue
samples corresponding to whole brain/B; olfactory
bulbs/OB, cerebral hemispheres/Part I, diencephalon/
mesencephalon/Part II, and cerebellum/medulla
oblongata/Part III, were taken for CYP1A mRNA,
CYP1A proteins/ELISA immunohistochemical analysis
and EROD activities
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Larvae
Fertilized seabream Sparus aurata eggs from a
commercial fish farm (CUPIMAR S.A, San Fernando,
Cadiz, Spain), were maintained under controlled
laboratory conditions until hatching. Physico-chemical
parameters, such as salinity (32‰), pH (7.5±0.2), and
dissolved oxygen (8.3±0.3 mg/L) were maintained at
appropriate values. From hatching and during 15 days
post-hatching/dph, larvae were transferred to 1-L glass
vessels (30 larvae per each vessel) and exposed to the
following treatments: (a) control (only toluene added),
(b) exposure to 0.3 µg/L B(a)P, (c) exposure to 0.5 µg/L
B(a)P during 24 h for toxicological studies. The
experimentas were performed in a termostatic chamber
at constant temperature (22±1°C)and photoperiod (12 h
light/ 12 h darkness). Groups of larvae from each one of
the 15 age classes (neonate, 2-15 dph) were exposed
during 24 h to B(a)P and inmediately euthanized with
200 mg/L and preserved for immunohistochemical and
biochemical purposes. The experiments for each
treatment groups (control and B(a)P exposure) were
carried out in triplicate. No mortalities were recorded
during the experimental period.
Experimental procedures and B(a)p concentrations
used in this work were previously described and justified
by Ortiz-Delgado and Sarasquete (2005) and Ortiz
Delgado et al. (2008).
CYP1A mRNA expression
For RNA extraction, 50-100 mg of whole brain
sample or of the various brain regions were mixed with 1
ml TRIZOL and homogenized. Two-hundred microliters
of chloroform were added, and the solution was
centrifuged at 10000xg for 15 min. The RNA-containing
supernatant was precipited by adding 500 µ l of
isopropanol and was centrifuged at 10000xg for 30 min.
After centrifugation, the pellet was washed with 1 ml
cold ethanol (70%), air dried and re-dissolved in DEPC-
H20 (diethyl pyrocarbonate, 0.1%). The RNA content
was quantified using UV spectrophotometer.
Fish-strand cDNA was produced following a
protocol of the SuperScript II RT kit (Boehringer
Mannheim, Germany) using 1 µg of total RNA. Two
microliters of the resulting cDNA were amplified in the
PCR reaction. PCR cycling conditions were as follow:
94°C for 45 s, 60°C for 30 s and 72°C for 35 s. The
CYP1A reaction was run in 35 cycles in order to be in
the linear range of product increase. The primer
sequences used for RT-PCR on seabream CYP1A
mRNA were taken from Cousinou et al. (2000).
The PCR products were electrophoresed on 1.6%
agarose gel and visualized with ethidium bromide
staining. Their identity was confirmed by sequencing 
CYP1A protein analysis
Protein concentrations in homogenates and
microsomes were determined by using the BIO-RAD Dc
(detergent compatible) protein kit which is based on a
modified Lowry method.
Western Blot 
Western blotting analyses were performed in order to
verify the specific cross-reactivity of the C-10-7
monoclonal antibody prepared against peptide 277-294
of rainbow trout (Oncorhynchus mykiss) CYP1A
(Biosense AS, Bergen, Norway) with the seabream
CYP1A protein. Microsomal preparations were
separated in 9% sodium dodecylsulfate polyacrylamine
gel electrophoresis (SDS-PAGE) (10 µg of protein/lane).
Transfer of the protein to nitrocellulose sheets was
performed in a Mini-Protean II blotting cell (Bio-rad)
according to the manufacturer’s procedures. The blots
were then probed overnight with a 1:200 diluted C10-7
antibody at room temperature and a peroxidase-
conjugated secondary anti-mouse IgG antibody from
goat. The immunoreaction was visualized using 4-
chloronaphtol as substrate for peroxidase. Molecular
weights of stained proteins on the Western blotting were
determined by comparing the relative mobilities with
molecular weight standards.
ELISA
An indirect ELISA method was performed according
to Goksøyr et al. (1991) and Scholz et al. (1997) in
whole brain and different cerebral parts after 20 days to
B(a)P. The microsomal samples were adjusted to a
protein content of 10 ng microsomal protein/ml. The
primary antibody used for the ELISA was the C10-7
CYP1A monoclonal antibody directed against peptide
277-294 of rainbow trout (Oncorhynchus mykiss)
CYP1A (Biosense AS, Bergen, Norway) diluted 1:500.
As previously pointed out by Ortiz-Delgado et al.,
(2005), the C10-7 antibody presented cross reactivity
with the CYP1A from S. aurata. The primary reaction
was followed by a horseradish-peroxidase-conjugated
goat IgG anti-mouse (Dako) as secondary antibody.
Staining was performed using 3,3’-diaminobenzidine as
substrate. The peroxidase reaction product was measured
as optical density in a spectrophotometer (Pharmacia,
Freiburg, Germany) at 405 nm; controls (non-specific
binding, blank) were included.
Immunohistochemistry of CYP1A
Sections of 5 µ m thickness of adult seabream,
Sparus aurata brain and whole larvae were prepared
from paraffin embedded samples. The sections after
blocking of unspecific binding sites were incubated
overnight in a humid chamber at room temperature with
the primary monoclonal mouse C10-7 CYP1A antisera
at dilution of 1:250. For further staining, the ABC kit
(Vectastain, USA) including a biotinylated anti-mouse
IgG secondary antibody was applied. Sections incubated
with normal fish serum instead of the primary antibody,
were used as negative controls.
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EROD analysis
EROD activity was measured as described by Scholz
et al. (1997). Tissue samples corresponding to whole
brain/B, olfactory bulbs/OB, cerebral hemispheres/Part I,
diencephalon/mesencephalon/Part II, cerebellum/
medulla oblongata/Part III, were homogenized in Tris-
based homogenisation buffer and microsomes were
prepared by means of ultracentrifugation (Scholz et al.,
1997). The microsomes were suspended in 200 µ l
homogenisation buffer and EROD activities were
determined in a microplate format assay using a
fluorometer plate reader (Fluostar, SLT-Tecan). The
assay was run with 47 µ M NADPH and 0.4 µ M
ethoxyresorufin in phosphate-buffered saline. The
concentrations of the reagents in the assay were
optimised in preliminary experiments. The rate of
resorufin formation in the assay was measured at an
excitation wavelength of 344 nm and at an emission
wavelength of 590 nm. A resorufin standard curve was
used to convert the fluorescent readings into the amount
of resorufin formed. Volume activity of EROD was
normalized to microsomal protein. 
Handling of the fish was always done according to
the European Union Directive (EEC, 1986) for the
protection of animals used for experimental and other
scientific purposes. All experimental procedures were
performed according to the Spanish Bioethical
Commission (CSIC and MEC).
Statistics
Results are presented as mean ± standard deviation
(S.D.). Significant differences were evaluated by means
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Fig. 1. Changes of CYP1A mRNA protein levels in liver and brain from S. aurata control and exposed individuals (100 µg B(a)P/L, during 20 days).
Changes of CYP1A levels in different brain regions of control and treated specimens at 5, 10, 15 and 20 days of exposure, were assessed by means of
RT-PCR (a1) and products of mRNA for CYP1A1 and ß-Actin (housekeeping gene) were analyzed by means of a densitometer (gel doc-BIORAD) (a2).
Hepatic changes of mRNA for CYP1A as a positive control assessed by means of RT-PCR (b1) and products of mRNA for CYP1A1 and ß-actin
(housekeeping gene) in liver samples analyzed by means of a densitometer (gel doc-BIORAD) (b2). Results are expressed as means ± S.D. (n= 9 fish
per each sampling point). Asterisks denote significant differences (p<0.05) with respect to the control group. OB: olfactory bulb; PI: part I; PII: part II;
PIII: part III. 
of a non-parametric ANOVA followed by the Tukey-
Kramer test. The significance level adopted was p<0.05.
Results
The expression and synthesis of CYP1A and
catalytic EROD activity show differences between the
brains of larval and adult seabream, Sparus aurata,
which may be related to ontogenetic changes in the
CYP1A expression patterns. A preferential site of
CYP1A expression is the olfactory bulbs. Throughout
the brain, vascular endothelia are immunoreactive to
CYP1A staining (Figs. 1-5). 
Adult fish
CYP1A mRNA 
In the brain of both control and B(a)P exposed adult
Sparus aurata specimens, the expression of CYP1A
mRNA was detectable only in telencephalon and here
specifically in the olfactory bulbs (OB). Other brain
regions (cerebral hemispheres, diencephalon-
mesencephalon and cerebellum-medulla oblongata) were
CYP1A-negative (Fig. 1a1,a2). Also, no expression was
detected in whole brain samples (data not shown).
Exposure to B(a)P (100 µg/L) did not induce significant
changes of CYP1A mRNA levels (Fig. 1a1,a2), whereas
hepatic CYP1A mRNA expression (used as positive
control) was markedly elevated (Fig. 1b1,b2). 
CYP1A proteins
Western blotting was used in order to verify a cross-
reactivity of the C10-7 commercial mouse antibody with
the CYP1A protein of S. aurata, using liver microsomes
from seabream and rainbow trout (positive control). In
the liver and brain of B(a)P exposed seabream fish, the
antibody detects specifically one single band of
approximately 60 kDa molecular weight (Fig. 2a),
indicating that C10-7 is specifically cross-reactive to
CYP1A of seabream.
For a detailed analysis of the regional distribution of
CYP1A in the brain, an immunoenzymatic assay/ELISA
was used. In both control and B(a)P exposed fish,
CYP1A was only found in olfactory bulb microsomes of
seabream, with the levels of control and B(a)P-exposed
fish being similar (Fig. 2b).
Immunohistochemistry of CYP1A
In adult Sparus aurata brain, CYP1A immuno-
staining was detected in neuronal fibers of the
glomerular layer of the olfactory bulbs. In the cerebral
hemispheres, the ventralis telencephali pars ventrali area
(vv) also contained CYP1A positive fibers and cell
bodies. The vascular endothelia of all brain regions were
strongly immunostained for Cyp1A (Fig. 3a,b). In
B(a)P-exposed seabream (100 µg/L B(a)P, 20 days of
exposure), an increase of CYP1A staining intensity was
detected in the neuronal fibers of the olfactory bulbs
(endothelium, fibers and glial cells), and particularly in
the vascular endothelia (Fig. 3c).
Catalytic activity
EROD activity was analyzed in microsomes from
homogenates of whole brain S. aurata specimens, as
well as of specific brain regions as described in the
Material and Methods section. Liver homogenates taken
from the same individuals used for brain analysis were
used as positive controls (Fig. 4). In the brains of Sparus
aurata exposed to 100µ g/L B(a)P for 20 days, no
cerebral EROD activity could be detected, neither in the
whole brain nor in specific brain regions (OB, Part I,
Part II and Part III). However, control liver samples
showed well detectable EROD levels (10 pmol resorufin
min-1 mg protein-1), as well as hepatic EROD activities
considerably increased after exposure to 100µg/L B(a)P
for 20 days (Fig. 4). These findings confirm the previous
observations of Ortiz-Delgado et al. ( 2008). 
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Fig. 2. a. Western blot of CYP1A protein in brain and liver from control
and exposed specimens (20 days of treatment). The amount of protein
applied to each lane was 20 µg. Liver of rainbow trout (O. mykiss) was
used as a positive control. (Lane 1: hepatic microsomes from 100 µg
B(a)P/L S. aurata exposed organisms; Lane 2: liver from rainbow trout;
Lane 3: microsomes from whole brain homogenates of B(a)P exposed
fish; Right lane: molecular weight marker). The antibody used was the
monoclonal antibody C10-7 (Biosense, Bergen, Norway) directed
against CYP1A of rainbow trout. b. Changes of CYP1A protein levels
assessed by means of Elisa technique in S. aurata exposed to 100 µg/L
during 20 days. Results are presented in means ± S.D. OB: olfactory
bulb; PI: part I; PII: part II; PIII: part III.
Larvae
By means of ELISA, RT-PCR and EROD, no
CYP1A expression could be detected in samples
prepared from whole seabream larvae, from hatching
until 15 dph.
In Sparus aurata larvae from hatching until 15 dph,
vascular brain endothelium, olfactory organ and folds of
the retina sensory cells showed basal CYP1A
immunoreactivity. The staining intensity increased
weakly during larval development, especially the
immunostaining of the brain endothelia (Fig. 5a-c). In
B(a)P-exposed larvae (0.3 and 0.5µg/L for 24 h), a
distribution of CYPIA similar to controls was observed
in vascular endothelium, retina and in olfactory elements
(olfactory organ (ciliated olfactory sensory neurons),
olfactory receptor neurons and olfactory bulbus) (Fig.
5d-f).
Discussion
Induction of CYP1A can enhance metabolism of
lipophilic xenobiotics. Basal expression of CYP1A as
well as xenobiotic induction shows inter- and intra-
species differences among teleosts, related to
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Fig. 4. EROD induction in the liver of B(a)P (100µg/L) exposed Sparus
aurata. Values represent means ± S.D. Asterisks denote significant
differences (p<0.05) with respect to the control group.
Fig. 3. Photomicrographs of transverse sections through the brain of S.
aurata, showing CYP1A immunoreactive cell bodies and neuronal
fibers. a. Strong CYP1A immunoreactivity in the glomerular layer (gl) of
the olfactory bulbs of control S. aurata brain. b. Ventralis telencephali
pars ventrali area (Vv) from control S. aurata brain showing CYP1A
immunoreactive fibers (arrows) and cell bodies (arrowheads). c. CYP1A
induction in cerebellum from B(a)P exposed fish (100 µg/L) restricted to
the vascular endothelia (ve). Scale bars: 100 µm.
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Fig. 5. CYP1A distribution in brain from Sparus aurata larvae.
5 dph control larvae showing a strong CYP1A immunostaining
widespread along the endothelium of vasculature
(arrowheads) (a) and located in the olfactory organ (oo) (b).
c. 5 dph control larvae showing CYP1A immunostaining in the
olfactive placoda (op). CYP1A immunoreactivity in the
olfactory bulb (ob), the retina (re) (d) and in olfactory reptor
neurons (arrowhead) (e) from 5 dph B(a)P exposed larvae
(0.5 µg/L for 24 h). f. Detail of the olfactory organ from 15 dph
exposed larvae (0.5 µg/L) showing strong CYP1A
immunoreactivity in the ciliated olfactory sensory neurons of
the olfactory organ (arrows) and in the olfactory receptor
neurons which connect the olfactory organ with the olfactory
bulb (arrowheads). Scale bars: 100 µm.
 
developmental patterns, to the respective target organ
and cells, to sex, to routes of incorporation (food, water,
sediment) and to concentration and type of contaminant,
i.e. metabolizable or persistent (Smolowitz et al., 1991,
1992; Stegeman et al., 1991; Goksøyr and Förlin, 1992;
Andersson and Goksøyr, 1994; Monod et al., 1994;
Stegeman and Hahn, 1994; Guiney et al., 1997;
Sarasquete and Segner, 2000; Arellano et al., 2001;
Ortiz-Delgado et al., 2002, 2005, 2008; Ortiz-Delgado
and Sarasquete, 2004; Hornung et al., 2007, among
others).
Adult Seabream brain
In brain of Sparus aurata adults, CYP1A was
constitutively expressed in both glial and neuronal cells
from mainly olfactory region, and it was expressed
throughout the brain in the vascular endothelia. Similar
regional and cellular distribution of CYP1A has been
reprorted for higher vertebrates (Walther et al., 1985),
and for other fish species (Smolowitz et al., 1992;
Monod et al., 1994; Gu et al., 2000; Ortiz-Delgado et al.,
2002). Because of the presence of CYPs in the synaptic
mitochondria of the nerve fibres, it was suggested that
xenobiotic oxidation and detoxification can occur inside
nerve endings. The strong induction of CYP1A in
cerebral glial cells is of significance, because these cells
are components of the blood-brain-barrier and also can
have a potential role in the toxication-detoxication
mechanisms (Walther et al., 1986, 1987). 
In fish species, due to the direct and continuous
contact of the olfactory organ to the external
environment, the cells of the olfactory system may be
potential targets of toxicant uptake, metabolism and
action, thereby contributing to neurotoxicity effects
(Smolowitz et al., 1992; Monod et al., 1994). The
presence of highly inducible CYP1A proteins in the
olfactory bulb and cerebellum is an interesting
observation, since both regions are readily accessible by
xenobiotics. The olfactory bulb serves the first
protection line in the brain because the olfactory
receptors neurons (via their apical dendrites) are in direct
and continuous contact with the external environment
(Chung-Davidson et al., 2004). Moreover, olfactory
receptor neurons innervating the olfactory bulbs provide
direct access to the central nervous system for certain
toxicants (Hastings and Evans, 1991).
In B(a)P exposed seabream, a CYP1A induction in
the brain was detectable only by immunohistochemical
techniques. This observation may be explained by a high
dilution of CYP1A-positive cells in the whole brain
homogenates, i.e. a specific increase in the CYP1A-
positive cells may turn undetectable in a whole brain
homogenate containing mainly CYP1A-negative cells.
In contrast to our findings on sea bream, in Fundulus
heteroclitus and Brachydanio rerio exposed to B(a)P, the
highest relative induction of CYP1A and mRNA
expression were detected in head, brain and testis, but
not in the liver (Hoffman and Oris, 2006; Wang et al.,
2006). 
No CYP1A catalytic activity was detected neither in
the whole brain nor in specific brain regions (olfactory
bulbs-cerebral hemispheres/part I, mesencephalon-
diencephalon/part II and cerebellum-medulla
oblongata/part IIII) of both control and B(a)P exposed
Sparus aurata specimens. Similar negative results were
indicated for TCDD exposed fish (Ortiz-Delgado et al.,
2002). EROD enzymatic levels in Sparus aurata brain
were too low to give an unequivocal signal in the
catalytic assays on brain homogenates. Interestingly,
CYP1A proteins are constitutively expressed and
synthesized in seabream brain, and especially in the
olfactory bulbs (endothelial and glial cells and nerve
fibers). A CYP1A induction by B(a)P was detected by
immunohistochemical analysis exclusively in seabream
brain. However, detectable levels of ß-naphtoflavone-
inducible EROD activity and CYP1A proteins were
observed in brain of both control and exposed rainbow
trout (Andersson and Goksoyr, 1994). In ß-
naphtoflavone exposed trout, a higher EROD induction
in olfactory organ than in liver was observed (Goksoyr
and Forlin, 1992).
In brain of Sparus aurata adults from the control
group, as previously pointed out (Ortiz-Delgado et al.,
2002), CYP1A immunoreactive neuronal fibers were
present in the glomerular layer of the olfactory bulbs. In
the cerebral hemispheres, the ventralis telencephali pars
ventrali area also contained CYP1A-positive fibers and
cell bodies. In addition to neuronal tissue, the endothelia
of the cerebral vascular system showed especially strong
CYP1A immunostaining. In B(a)P-exposed seabream , a
strong induction of CYP1A was detected in olfactory
bulbs (glia, nerve fibres) and in the endothelia of the
brain vascular system. CYP1A induction after
xenobiotic exposure was also detected in chemosensory
structures (olfactory and taste bud epithelia) of
topminnows, Poeciliopsis sp exposed to B(a)P
(Smolowitz et al., 1992). A constitutive CYP1A
immunoreactivity was detectable only in the non-sensory
epithelium of the olfactory organ, whereas in ß-
naphtoflavone-exposed fish, CYP1A localization
extends to the sensory epithelium (Saucier et al., 1999).
CYP1A was clearly induced by ß-naphtoflavone in the
olfactory bulbs (endothelial and glial cells and the nerve
fibers) and the valvula of the cerebellum. In contrast, in
the juvenile lake trout, Salvelinus namaycush, both
control and exposed ß-naphtoflavone juvenile lake trout,
showed similar CYP1A immunoreactivities in
endothelia, glial cells and neurons, in the tectum
mesencephali, corpus cerebelli and in the accessory
cerebelloid structure (Chung-Davidson et al., 2004). In
the brain of TCDD-exposed seabream, a strong
induction of CYP1A mRNA and protein, but not of
EROD activity was detected (Ortiz Delgado et al.,
2002). Interestingly, TCDD-exposed fish showed
CYP1A-immunoreactive fibres and cell bodies in the
telencephalon (terminal nerve ganglion cells, cerebral
hemispheres), mesencephalon (neuronal cells and fibers
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on the optic tectum and tegmentum, diencephalon
(preoptic area), mesencephalon, rombencephalon (area
octavolateralis, 3trd ventricule), cerebellum (valvula
cerebeli, corpus cerebeli and lobus vestibulolateralis)
and adenohypophysis (Ortiz-Delgado et al., 2002).
Larval brain 
At hatching and during larval ontogeny of seabream,
CYP1A was already expressed in the developing brain.
The early appearance of basal and inducible CYP1A is
important for the ability of fish embryos and larvae to
metabolize, eliminate and eventually detoxify
endogenous substances and lipophilic xenobiotics
(Sarasquete and Segner, 2000). In medaka, Oryzias
latipes, when the larval gastrointestinal tract became
functional a few days after hatching, the B(a)P
metabolites were rapidly eliminated (Hornung et al.,
2007). These findings indicate that some of the earliest
embryonic tissues are metabolically competent and that
redistribution of benzo(a)pyrene and its metabolic
products occurs throughout development. Rapid
metabolism of B(a)P substantially reduces the body
burden of the parent chemical in the developing embryo,
potentially reducing toxicity (Hornung et al., 2007). 
The cellular staining for CYP1A was often weak in
tissues of young fish, except for the vascular endothelia,
which showed a comparatively strong immunoreactivity
(Reinecke and Segner, 1998; Sarasquete et al., 1999,
2001). Strong inducibility of CYP1A by lipophilic
xenobiotics (dioxins, ß-naphthoflavone), in the vascular
endothelia of fish has been reported by several authors
(Guiney et al., 1997; Chung-Davidson et al., 2004;
Ortiz-Delgado and Sarasquete, 2004). 
During larval growth of Sparus aurata, CYP1A
immunostaining was detected from hatching onwards in
olfactory placode, endothelia of the vascular system and
in retina sensory cells. Staining intensity was increasing
progressively during larval development. A similar
tissue distribution and intensity of CYP1A
immunostaining as in control seabream larvae was
detected in the brains of B(a)P-exposed larvae. Sea
bream larvae exposed to TCDD, which is one of the
most potent inducers of CYP1A, also showed an
induction of CYP1A in neuronal cells in the proximity
of the olfactory bulbs (Ortiz-Delgado and Sarasquete,
2004). No CYP1A induction, in somatic or cerebral
areas, was detected in seabream larvae exposed to
sublethal concentrations of linear alkylbenzene
suphonate (Hampel et al., 2004). Recently, Brzuzan et al.
(2007) observed elevated levels of CYP1A mRNA in the
brain of juvenile trout after exposure to B(a)P. Overall, it
appears that accumulation of AhR-binding xenobiotics
by fish can result in an induction of AhR-regulated
genes such as CYP1A in the fish brain, with possible
adverse consequences on brain development and
function. 
In fish brain, basal CYP1A immunoreactivities in
endothelia, glial cells and neurons have been observed in
larvae, juvenile and adult fish species (Smolowitz et al.,
1991; Stegeman et al., 1991; Reinecke and Segner, 1998;
Sarasquete et al., 1999, 2001; Sarasquete and Segner,
2000; Arellano et al., 2001; Ortiz-Delgado et al., 2002;
Ortiz-Delgado and Sarasquete, 2004). According to
Chung-Davidson et al. (2004), in Salvelinus namaycush
exposed to ß-naphtoflavone, most of glial cells that
showed CYP1A immunoreactivities were attached to the
blood vessels. It is likely that these glial cells can absorb
xenobiotic chemicals from the blood vessels and they
constitutively produce CYP1A proteins to serve a
protective function by eliminating exogenous and
metabolic substances from the central nervous system.
Interestingly, as previously pointed out (Walther et al.,
1986, 1987), the xenobiotic oxidation and detoxification
can occur inside nerve endings.
In different fish species, including Sparus aurata,
the endothelia of the vascular system of different
cerebral and somatic organs and tissues showed basal
levels of CYP1A proteins and a strong xenobiotic
CYP1A induction (Sarasquete et al., 1999, 2001;
Sarasquete and Segner, 2000; Arellano et al., 2001;
Ortiz-Delgado et al., 2002, 2005, 2007; Ortiz-Delgado
and Sarasquete, 2004). Endothelial cells are the first site
of interaction with blood-borne toxicants, and it has been
suggested that the vascular endothelium with its wide
range of physiological functions (i.e vasoactive
regulators, such as arachidonic acid metabolites,
prostaglandins, steroids, etc) may be the primary target
for the toxic action of CYP1A-inducing substances
(Stegeman and Hahn, 1994). At the same time,
endothelial cells are involved in the transfer of chemicals
from the blood to the underlying cells and tissues
(Guiney et al., 1997; Sarasquete and Segner, 2000).
Potentially, CYP1A induction and “first pass”
metabolism in vascular endothelial cells may protect the
underlying cells from toxic pollutants. Additionally,
activated intermediate metabolites in the endothelial
cells may affect both the cells and the underlying
parenchymal cells. The toxicity of AhR ligands appears
to correlate with CYP1A induction in endothelia, and
activation of toxicants could contribute to endothelial
damage and vascular pathologies (Cantrell et al., 1996;
Guiney et al., 1997; Henry et al., 1997; Goksoyr and
Husoy, 1998; Chung-Davidson et al., 2004). 
In conclusion, from hatching onwards Sparus aurata
expresses immunoreactive CYP1A in the brain, with
preferential localization in the cerebral endothelia and in
sensory organs (olfactory placode and retina) although
no measurable CYP1A induction was detected in B(a)P
exposed larvae. Expression levels increase during
ontogeny (somatic and brain tissues), In adult male
seabream, CYP1A proteins appear to be expressed
constitutively at very low levels in the brain
parenchyma, and the expression of CYP1A in the
olfactory bulbs and endothelia can be weakly induced by
B(a)P exposure. Thus, B(a)P reaching the brain via
blood could be metabolized at least partly metabolized
already in the cerebral endothelial system.
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From a technical point of view, the use of
immunohistochemical methods is particularly advisable
for heterogeneously composed tissues such as the brain
containing only a small fraction of CYP1A-positive
cells. 
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